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Sir,  
In their commentary, Pulcini et al. (1) compared staffing recommendations for antibiotic stewardship 
(AS) teams in hospitals from different countries including the sources used to define these 
recommendations and called for further studies on staffing standards. However, before conducting 
new studies, we think it is important to assess the currently available evidence on this topic. We 
therefore re-analyzed two recently published systematic reviews on AS programs (2, 3). We 
extracted information on human resources used in the included studies from the original 
publications. A total of 19 studies were identified which reported details on AS team composition 
(Table 1). The studies were published between 2003 and 2016 and were conducted in 13 different 
high- or middle-income countries. The AS programs assessed in these studies widely differed in 
structure, components, and focus of the intervention (e.g. fluoroquinolone restriction or prescribing 
quality in general). The settings in which the AS programs were implemented showed a high 
variability, ranging from 12-bed ICU to 1800-bed hospital. Consequently, the AS teams reported in 
the publications varied in size and composition, ranging from one infectious disease physician to 
large teams with more than ten members. Remarkably, only six studies reported estimates of full-
time equivalents, while in 11 publications it was unclear how much effort and time were spent by the 
individual members of the AS teams to implement and conduct the program. In some papers, 
information on staffing of the AS program was hidden in the Discussion section. Moreover, we 
suspect that both systematic reviews analyzed here did not comprehensively cover this topic since 
several studies which provide details on human resources were not included (4, 5). Information on 
staffing is essentially needed to compare AS programs and to provide exact calculations in terms of 
human resources and costs. Therefore, we suggest that detailed reporting of human resources used 
in relation to the respective setting should become standard for publications on AS programs, 
preferentially in the Methods and Results sections of the paper. In that sense, we would welcome 
the inclusion of a respective item in the recently published reporting checklist for epidemiological 
studies on antimicrobial resistance (STROBE-AMS) under methods setting and generalizability (6). To 
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our opinion, this will greatly enhance the value of reports on AS programs and pave the way towards 
informing and developing evidence-based recommendations on human resource needs for AS 
programs.    
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Table 1 
Studies on antimicrobial stewardship programs with information on human resources (AS team) 
Study Country Program description Setting AS team  
Amer et al., 2013(7) Saudi Arabia Preapproval strategy; 
audit and feedback; 
education; guidelines; 
dose optimization; 
antimicrobial cycling  
20-bed ICU - Intensivist/ID physician 
- ASP pharmacist 
Apisarnthanarak et al., 
2006 (8) 
Thailand Education; feedback; 
bedside discussion; 
prescription forms; 
antibiogram; 
computerized system 
recording 
350-bed tertiary 
care university 
hospital 
- ID physician 
- clinical microbiologist 
- 4 pharmacists 
- 2 internists 
- hospital epidemiologist 
- IC specialist 
- computer system 
analyst 
Bantar et al., 2003 (9)  Argentina AB order form; feedback; 
bedside discussion 
250-bed teaching 
hospital + 10-bed 
ICU 
- ID physician 
- clinical microbiologist 
- laboratory 
microbiologist 
- 2 pharmacists  
- internist 
- computer system 
analyst 
Borde et al., 2014 (10) Germany Guideline; information 
and education; regular 
ward rounds and 
intensified ID 
consultations; feedback 
and audit 
300-bed medical 
service (of 1600 
bed academic 
teaching hospital) 
- Senior physician (0.35 
FTE) 
- ID fellow (0.75 FTE) 
- Pharmacist (0.12 FTE) 
- Data manager (0.06 
FTE) 
Borde et al., 2015 (11) Germany  Daily rounds; written 
guidelines 
200-bed 
community 
hospital + 10-bed 
ICU 
- ID physician (0.25 FTE) 
 
Boyles et al., 2013 (12) South Africa AB prescription chart; ABS 
ward rounds; audit 
two 32-bed 
medical wards 
- ID specialist 
- consultant 
microbiologist 
- IC nurse 
- ward pharmacist 
Cisneros et al., 2014 (13) Spain Counseling interviews; 
guidelines 
1251-bed tertiary 
care teaching 
hospital with 90 
ICU beds 
- ID specialist 
- pharmacist 
- intensive care specialist 
- paediatrician 
- microbiologist 
- expert in clinical 
documentation 
Cook et al., 2004(14) USA Enhanced feedback after 
two preauthorization 
approvals for restricted 
AB; treatment days for 
controlled AB  
731-bed tertiary 
care teaching 
hospital 
- ID physician 
- pharmacist 
Leung et al., 2011 (15) Canada Audit and feedback 12-bed ICU - Physician (0.5 FTE) 
- Pharmacist (1.0 FTE) 
Lin et al., 2013 (16) Taiwan Restriction; education; 
ward rounds; bedside 
evaluation; audit 
415-bed 
community public 
teaching hospital 
- Infection specialist 
(0.60 FTE) 
- 2 pharmacists (0.5 FTE 
each) 
- 2 infection control 
nurses (0.2 FTE each) 
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Malani et a., 2013 (17) 
 
USA Audit 
 
 
535-bed hospital - 2 ID physicians (0.3 FTE 
total)  
- 3 critical care 
clinical pharmacists (no 
dedicated stewardship 
time) 
Marra et al., 2009 (18) 
 
Brazil AB restriction and audit 
 
 
38-bed medical-
surgical unit 
- ID physician  
- pharmacist 
Meyer et al., 2007 (19) Germany Guideline; education 12-bed ICU - IC specialist 
- infection control 
physician 
- occasionally: 
microbiologist,  
pharmacist 
Ng et al., 2008 (20) Hong Kong Guideline; education; 
feedback; monthly AB 
consumption; cost 
monitoring; AB 
susceptibility reporting 
1800-bed hospital - physicians 
- microbiologist 
- ID specialist 
- pharmacist 
(detailed cost calculation 
reported) 
Niwa et al., 2012 (21) Japan Review of AB orders; 
restricted duration of use; 
education; feedback; 
printed information  
606-bed 
university hospital 
- IC doctor 
- pharmacist 
- nurse 
- microbiological 
technologist 
Pate et al., 2012 (22) USA Audit; consultation 60-bed hospital - medical director for 
infection control (10 
hours/month) 
- director 
of pharmacy (clinical 
pharmacist; (5 
hours/week) 
Storey et al., 2012 (23) USA Audit; feedback 43-bed medical-
surgical services 
- ID physician medical 
director of infection 
control 
- clinical pharmacy 
supervisor 
- pharmacy director 
Takesue et al., 2010 (24) 
 
Japan AB cycling; restriction; 
audit 
 
 
910-bed 
university hospital 
- 2 ID physicians 
- pharmacist 
- IC nurse  
- additional input from a 
microbiologist 
Yeo et al., 2012 (25) Singapore Audit; feedback 990-bed tertiary 
public teaching 
hospital 
- clinical pharmacist (full-
time) 
- clinical microbiologist 
(0.1 FTE) 
- ID physician (0.1 FTE) 
AB, antibiotics; ASP, antimicrobial stewardship program; FTE, full-time equivalent; IC, infection control; ICU, intensive care 
unit; ID, infectious disease
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